{
    "title": "Yellow fever vaccine: worthy friend or stealthy foe?",
    "doc_id": "27087465",
    "writer": "Seligman SJ",
    "year": "2016",
    "summary": "Recognition that the live yellow fever vaccine may rarely be associated with viscerotropic disease (YEL-AVD) has diminished its safety status. However, the vaccine remains the principal tool for limiting the occurrence of yellow fever, making large por â€¦",
    "abstract": "Recognition that the live yellow fever vaccine may rarely be associated with viscerotropic disease (YEL-AVD) has diminished its safety status. However, the vaccine remains the principal tool for limiting the occurrence of yellow fever, making large portions of Africa and South America more habitable. The subject has previously been exhaustively reviewed. Novel concepts in the current report include the description of a systematic method for deciding whom to vaccinate, recommendations for obtaining data helpful in making that decision, and suggestions for additional study. The vaccine is indeed a worthy friend, but its adverse reactions need to be recognized.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/27087465/"
}